BASF Catalysts India Private Limited inaugurates a new RD&A lab for automotive emissions control solutions
04 août 2024 22h30 HE
|
BASF Environmental Catalyst and Metal Solutions LLC
The strategic investment in Chennai is focused on development of emissions control catalysts tailored to the unique needs of the Indian automotive market.
[Latest] Global Refinery Catalyst Market Size/Share Worth USD 12.6 Billion by 2033 at a 5.2% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value)
25 juin 2024 13h00 HE
|
Custom Market Insights
Austin, TX, USA, June 25, 2024 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “Refinery Catalyst Market Size, Trends and Insights By Type (Zeolites, Metallic,...
[Latest] Global Catalyst Market Size/Share Worth USD 45.8 Billion by 2033 at a 4.9% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value)
17 avr. 2024 12h30 HE
|
Custom Market Insights
Austin, TX, USA, April 17, 2024 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “Catalyst Market Size, Trends and Insights By Raw Material (Chemical Compounds,...
Blue Biofuels Initiates Engineering and Design for Their CTS Commercial Plant Positioned to Produce Ethanol from Cellulosic Materials
16 avr. 2024 08h00 HE
|
Blue Biofuels, Inc.
PALM BEACH GARDENS, FL, April 16, 2024 (GLOBE NEWSWIRE) -- Blue Biofuels, Inc. (OTCQB: BIOF). In a recent development, Blue Biofuels Inc. (“BIOF”) proudly announces the commencement of an FEL...
Catalyst Pharmaceuticals Reports FDA Approval of AGAMREE® (vamorolone) for Duchenne Muscular Dystrophy Granted to Santhera Pharmaceuticals
26 oct. 2023 15h19 HE
|
Catalyst Pharmaceuticals, Inc.
AGAMREE® Indicated for the Treatment of Duchenne Muscular Dystrophy for Patients Aged Two Years and Older Catalyst Holds the Exclusive North American License to Commercialize AGAMREE (vamorolone) for...
Catalyst Pharmaceuticals Announces FDA Acceptance of the Supplemental New Drug Application for FIRDAPSE®
13 oct. 2023 08h03 HE
|
Catalyst Pharmaceuticals, Inc.
The sNDA Seeks to Increase the Indicated Maximum Daily Dose for FIRDAPSE to 100mg for the Treatment of Lambert-Eaton Myasthenic Syndrome U.S. FDA Assigned Target Action Date of June 4, 2024 CORAL...
Ruthenium Tetroxide Market revenue to reach USD 2 Billion by 2035, says Research Nester
13 sept. 2023 07h52 HE
|
Research Nester
New York, Sept. 13, 2023 (GLOBE NEWSWIRE) -- The global ruthenium tetroxide market is estimated to grow at a CAGR of ~9% over the forecast period. The market is estimated to garner a revenue of ~USD...
Emission Control Catalyst for Marine Market to Experience Significant Growth CAGR of 6.3% - Market Report by RationalStat
31 août 2023 10h30 HE
|
Rationalstat LLC
Wilmington, Delaware, Aug. 31, 2023 (GLOBE NEWSWIRE) -- Global Emission Control Catalyst for Marine Market is valued at US$ 878.3 million in 2022 and is expected to grow at a significant CAGR of...
Catalyst Market to Surpass 48.9 Billion by 2030 Drives Due to the Increasing Demand from the Automobile Industry
23 août 2023 10h45 HE
|
SkyQuest Technology Consulting Pvt. Ltd.
Westford,USA, Aug. 23, 2023 (GLOBE NEWSWIRE) -- According to SkyQuest, there is a growing demand for catalysts that enable the conversion of bio-derived feedstock into industrially relevant...
Catalyst Pharmaceuticals Reports Strong Second Quarter 2023 Financial Results and Provides Corporate Update
09 août 2023 16h17 HE
|
Catalyst Pharmaceuticals, Inc.
Achieved Record Q2 2023 Total Net Revenues of $99.6 MillionAchieved FIRDAPSE® 2023 Second Quarter Net Revenues of $64.9 Million, a 22% Increase YOYAchieved 2023 Second Quarter GAAP EPS Diluted of...